| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 07/28/2005 | CA2551128A1 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifiying and obtaining the polymorphs thereof |
| 07/27/2005 | EP1556436A1 Polyamine derivatives, a process to make them, and their use |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | CN1646483A Photostable cationic organic sunscreen compounds with antioxidant properties and compisitions obtained therefrom |
| 07/27/2005 | CN1646481A Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/26/2005 | US6921839 Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem |
| 07/21/2005 | WO2005065361A2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof |
| 07/21/2005 | WO2005042480A3 N-substituted pyrazolyl carboxanilides |
| 07/20/2005 | EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors |
| 07/20/2005 | EP1299348A4 Compounds and compositions for delivering active agents |
| 07/20/2005 | CN1642914A Certain 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor XA |
| 07/19/2005 | US6919476 Simple and efficient preparation of an amino acid, alpha-tertiary-butoxycarbonylaminoethylamino-),alpha-(alkyl-)acetic acid; used to prepare peptide nucleic acids (PNA) including those having photosensitive functional groups |
| 07/19/2005 | US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists |
| 07/14/2005 | WO2005063690A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 07/14/2005 | WO2005063689A1 Benzamide derivative |
| 07/14/2005 | WO2005063688A1 Sphingolipid-rucinol derivatives and composition for skin external use containing the derivatives |
| 07/14/2005 | WO2005063665A1 Propofol analogs, process for their preparation, and methods of use |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR |
| 07/14/2005 | WO2005062874A2 Compounds and compositions for delivering active agents |
| 07/14/2005 | WO2005062811A2 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates |
| 07/14/2005 | WO2005051893A3 Vitamin d receptor modulators |
| 07/14/2005 | WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/14/2005 | US20050154220 Particularly Latanoprost; 1,4 addition of a cuprate reagent of a protected 5-iodo-3-hydroxy-4-pentenylbenzene; stereoselective reduction; protection of hydroxyl groups; dihydroxylation; reduction; diol cleavage; Wittig reaction: esterification or amidation; and deprotection; intermediates |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154062 Substituted chiral allosteric hemoglobin modifiers |
| 07/14/2005 | US20050153366 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 07/14/2005 | CA2551567A1 Propofol analogs, process for their preparation, and methods of use |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/13/2005 | EP1553075A1 Lpa receptor antagonists |
| 07/13/2005 | EP1551795A1 Inhibitors of histone deacetylase |
| 07/13/2005 | EP1551793A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 07/13/2005 | EP1315695B1 Benzene tricarboxylic acid amides as insulin receptor activators |
| 07/13/2005 | CN1639138A Biphenylmethyl-thiazolidinediones and analogues and their use as PPAR-gamma activators |
| 07/13/2005 | CN1639112A Substituted amides active at the cannabinoid-1 receptor |
| 07/13/2005 | CN1639111A Process for preparing 2-aminoindan derivatives |
| 07/13/2005 | CN1639110A Haloacetamide and azide substituted compounds and methods of use thereof |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636457A Fungicides for the control of take-all disease of plants |
| 07/13/2005 | CN1210278C Ketol fatty acid derivatives, preparing method and plant growth regulating agents |
| 07/13/2005 | CN1210254C Vanilloid analogues containing resiniferatoxin pharmacophores as potent vannilloid receptor agonists and analgesics, compositions and uses thereof |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916948 Bis(1,3-dihydroxy-prop-2-yl) amine and derivatives thereof in the manufacture of polymers |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916778 Sunscreen agents; laundery pretreatment/aftertreatment |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916461 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 07/07/2005 | WO2005061442A1 Opioid receptor antagonists |
| 07/07/2005 | WO2005061441A1 Selective peroxisome proliferator activated receptor modulators |
| 07/07/2005 | WO2005060603A2 Nitric oxide releasing pyruvate compounds, compositions and methods of use |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | US20050148670 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 07/07/2005 | US20050148656 Carboxylic derivates |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148549 Compositions and methods for inhibition of phospholipase a2 mediated inflammation |
| 07/07/2005 | US20050147909 electrophotographic toners comprising binder resins, colorants and charge control agents consisting of naphthol derivatives, having excellent negative chargeability, dispersion in and compatibility with binders |
| 07/07/2005 | US20050147662 Compounds and compositions for delivering active agents |
| 07/07/2005 | US20050147563 Imaging lymph nodes with a Gadolinium complex of 10-[2-hydroxy-4-aza-5-oxo-7-aza-7-(perfluorooctylsulfonyl)-nonyl]-1,4,7-tris (carboxymethyl)-1,4,7,10-tetraazacyclododecane; in vivo contrast media in nuclear spin tomography; blood-pool agents, lymphographic agents |
| 07/07/2005 | CA2549412A1 Nitric oxide releasing pyruvate compounds, compositions and methods of use |
| 07/07/2005 | CA2549009A1 Opioid receptor antagonists |
| 07/07/2005 | CA2549008A1 Selective peroxisome proliferator activated receptor modulators |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN1635833A Biocide compositions and methods and systems employing same |
| 07/06/2005 | CN1634883A Process for preparing 2-substituted enamine or enoyl amine |
| 07/06/2005 | CN1634874A N-methyl (p-phenoxy, phenoxy) acetamide and its preparation method |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 06/30/2005 | WO2005058845A2 Novel glucagon antagonists/inverse agonists |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050142156 Mono- or di-C-substituted diketopiperazines, e.g., the diketopiperazine of L-Glutamic Acid, are carriers for drug delivery of a wide variety of drugs including biodrugs; oral dosage forms |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/29/2005 | EP1548004A1 Biological low-molecular weight derivatives |
| 06/29/2005 | EP1547999A1 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546088A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 06/29/2005 | EP1546074A1 Method for the production of at least one partial propylene oxidation and/or ammoxidation product |
| 06/29/2005 | EP1546073A1 Method for the production of at least one partial propylene oxidation and/or ammoxidation product |
| 06/29/2005 | CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/28/2005 | US6911556 Processes for the preparation of olefins, unsaturated carboxylic acids and unsaturated nitriles from alkanes |
| 06/28/2005 | CA2245953C A process for the production of a condensation product of a carboxylic acid |
| 06/28/2005 | CA2125679C Novel amino acid derivatives |
| 06/23/2005 | WO2005057207A1 Trityl derivatives for enhancing mass spectrometry |
| 06/23/2005 | WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 06/23/2005 | WO2005056516A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137172 Haloacetamide and azide substituted compounds and methods of use thereof |
| 06/23/2005 | US20050136029 Microbiocide preservatives, use in drugs or disinfecting contact lenses; polyoxypeopylene glycol with end groups, or propylene oxide adducts |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/22/2005 | EP1543148A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1175392B1 Contrast media |